No Data
No Data
Attention is focused on Sakata Seed and Stem Inc, while Yorozu is somewhat weak.
Last weekend on the 17th, in the U.S. stock market, the Dow Jones Industrial Average rose by 334.70 dollars to 43,487.83, the Nasdaq Composite Index increased by 291.91 points to 19,630.20, and the Chicago Nikkei 225 Futures was up by 325 yen compared to the Osaka daytime at 38,795 yen. The exchange rate was 1 dollar = 156.30-40 yen. In today's Tokyo market, Stem Inc <3771> announced a revision of the Financial Estimates for dividends for the fiscal year ending March 2025, and Sakata Seed Corporation <1377> announced a Share Buyback not exceeding 1.59% of the issued shares and a bid for purchase.
Yorozu, downward revision for 25/3, operating loss of 1.2 billion yen, down from 4.5 billion yen.
Yorozu <7294> announced a revision of its financial estimates for the fiscal year ending March 2025. Revenue was revised down from 180 billion yen to 177 billion yen, and operating loss was adjusted from a profit of 4.5 billion yen to a loss of 1.2 billion yen. Due to volatility in the Foreign Exchange market, an extraordinary expense (foreign exchange losses) was recorded. Furthermore, the number of passengers carried at the major client NISSAN MOTOR CO <7201> decreased in China ETC, leading to a decline in sales. [Positive Evaluation] <5341> ASAHI GROUP HOLDINGS Full Year | <3690> Ilglum Revision <964>
<Today's Individual Materials> S Research, Ai Robo, TMN, Netyear, ETC (announced on the 17th).
▽ S Research <3771.T>, the year-end Dividends forecast for the fiscal year ending March 2025 has been increased from the previous 40 yen to 60 yen (considering the previous period's performance of 40 yen adjusted for a 1-for-2 Stock Split) ▽ Ai Robo <247A.T>, introduced a shareholder benefit program that gifts 9,000 yen worth of their products to shareholders holding one unit (100 shares) or more as of the record date ▽ TMN <5258.T>, downwardly revised the consolidated performance forecast for the fiscal year ending March 2025 ▽ Netyear <3622.T> - lowered the standalone performance forecast for the fiscal year ending March 2025 ▽
The key points of the PTS on the 17th = Ilgloom, Ajuban H, Kyowa Consulting, ETC.
▽ Ilgurm <3690.T> discloses the consolidated financial estimates and dividends estimates for the fiscal year ending September 2025, expecting increased revenue, profit, and dividends. ▽ Ajuvan H <4929.T>, the consolidated performance for the third quarter cumulative of the fiscal year ending March 2025 (from March 21, 2024 to December 20, 2024) shows significant profit increase. ▽ Kyouwa Consulting <9647.T>, the consolidated results for the fiscal year ending November 2024 diverge from plans, while an increase in revenue and profit is expected for the fiscal year ending November 2025. ▽ AHC <7083.T>, expects double-digit operating profit growth and an increase in dividends for November 2025. ▽ Kaneko Seed.
Adjuvant Holdings: Presentation of financial results for the 3rd quarter of the fiscal year ending March 31, 2025
Adjuvant Holdings: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)